OneAscent Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$405K Buy
6,677
+80
+1% +$4.66K 0.41% 65
2025
Q4
$356K Sell
6,597
-74
-1% -$3.56K 0.38% 76
2025
Q3
$301K Sell
6,671
-2,659
-28% -$124K 0.32% 96
2025
Q2
$432K Buy
9,330
+4,302
+86% +$211K 0.46% 59
2025
Q1
$307K Buy
+5,028
New +$293K 0.36% 84

Other funds holding BMY

OneAscent Investment Solutions's BMY Position: Q1 2026 in Review

OneAscent Investment Solutions increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, buying an estimated $4.66K and bringing the position to 6,677 shares worth $405K. The position accounts for 0.41% of the portfolio, ranked #65.

OneAscent Investment Solutions first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $432K in Q2 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • OneAscent Investment Solutions held 6,677 shares of Bristol-Myers Squibb worth $405K as of Q1 2026.
  • OneAscent Investment Solutions bought 80 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.66K.
  • Bristol-Myers Squibb made up 0.41% of OneAscent Investment Solutions's portfolio in Q1 2026, its #65 holding.
  • OneAscent Investment Solutions first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • OneAscent Investment Solutions's Bristol-Myers Squibb position peaked at $432K in Q2 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on OneAscent Investment Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.